Related Experiment Videos
Development of a new pulsatile ventricular assist device.
Tatsuya Kurosaki1, Hiroshi Sakai, Shinji Ninomiya
1Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. kurosakt@hiroshima-u.ac.jp
Hiroshima Journal of Medical Sciences
|April 6, 2006
Summary
Researchers developed a small, low-cost implantable ventricular assist device (VAD) for smaller patients. This novel VAD fabrication is simple, efficient, and compatible with existing IABP control units.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Cardiovascular Technology
Background:
- Ventricular assist devices (VADs) are crucial for managing heart failure.
- Existing VADs are often large, limiting their use in smaller patient populations.
- There is a need for smaller, more accessible VADs.
Purpose of the Study:
- To develop a small, lightweight, and low-cost implantable VAD.
- To optimize the VAD design for smaller Japanese subjects.
- To assess the feasibility and performance of the novel VAD.
Main Methods:
- Fabrication using a simple turning process from acrylic blocks and a silicon diaphragm.
- Flow visualization techniques to determine the most efficient pump shape.
- Performance testing under simulated physiological conditions (300/-100 mmHg).
- 30-day continuous driving performance test.
Main Results:
- The Ebacor VAD is small, lightweight, and low-cost.
- Achieved an output exceeding 6 liters/min.
- Demonstrated compatibility with standard intra-aortic balloon pump (IABP) control units.
- Successful 30-day continuous operation without performance degradation or leakage.
Conclusions:
- The developed Ebacor VAD offers a promising solution for smaller patients requiring circulatory support.
- Its simple fabrication and compatibility with existing equipment enhance its clinical applicability.
- Further research may explore its long-term efficacy and broader patient suitability.